vs
Indivior Pharmaceuticals, Inc.（INDV）与Stitch Fix, Inc.（SFIX）财务数据对比。点击上方公司名可切换其他公司
Indivior Pharmaceuticals, Inc.的季度营收约是Stitch Fix, Inc.的1.0倍（$357.0M vs $342.1M），Indivior Pharmaceuticals, Inc.净利率更高（28.9% vs -1.9%，领先30.7%），Stitch Fix, Inc.自由现金流更多（$5.6M vs $-245.0M）
Indivior是一家全球专科制药企业，专注于开发和商业化针对阿片类物质使用障碍、酒精依赖及相关精神健康疾病的循证治疗方案，核心市场覆盖北美与欧洲，旗下多款获批疗法服务于医疗需求未被充分满足的患者群体。
Stitch Fix是美国的在线个人造型服务平台，依托推荐算法与数据科学技术，根据顾客的身形尺寸、预算和风格偏好推送个性化服饰单品。该公司创立于2011年，2017年完成首次公开募股，目前总部位于旧金山。
INDV vs SFIX — 直观对比
营收规模更大
INDV
是对方的1.0倍
$342.1M
净利率更高
INDV
高出30.7%
-1.9%
自由现金流更多
SFIX
多$250.6M
$-245.0M
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $357.0M | $342.1M |
| 净利润 | $103.0M | $-6.4M |
| 毛利率 | 82.1% | 43.6% |
| 营业利润率 | 22.7% | -2.5% |
| 净利率 | 28.9% | -1.9% |
| 营收同比 | — | 7.3% |
| 净利润同比 | 390.5% | -1.7% |
| 每股收益（稀释后） | $0.79 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INDVSFIX
| Q4 25 | $357.0M | $342.1M | ||
| Q3 25 | $314.0M | $311.2M | ||
| Q2 25 | $302.0M | $325.0M | ||
| Q1 25 | $266.0M | $312.1M | ||
| Q4 24 | — | $318.8M | ||
| Q3 24 | $307.0M | $319.6M | ||
| Q2 24 | $299.0M | $322.7M | ||
| Q1 24 | — | $330.4M |
净利润INDVSFIX
| Q4 25 | $103.0M | $-6.4M | ||
| Q3 25 | $42.0M | $-8.6M | ||
| Q2 25 | $18.0M | $-7.4M | ||
| Q1 25 | $47.0M | $-6.5M | ||
| Q4 24 | — | $-6.3M | ||
| Q3 24 | $22.0M | $-36.5M | ||
| Q2 24 | $-97.0M | $-21.3M | ||
| Q1 24 | — | $-35.5M |
毛利率INDVSFIX
| Q4 25 | 82.1% | 43.6% | ||
| Q3 25 | 73.2% | 43.6% | ||
| Q2 25 | 82.8% | 44.2% | ||
| Q1 25 | 83.1% | 44.5% | ||
| Q4 24 | — | 45.4% | ||
| Q3 24 | 78.5% | 44.6% | ||
| Q2 24 | 73.6% | 45.5% | ||
| Q1 24 | — | 43.4% |
营业利润率INDVSFIX
| Q4 25 | 22.7% | -2.5% | ||
| Q3 25 | 13.7% | -3.6% | ||
| Q2 25 | 23.8% | -3.0% | ||
| Q1 25 | 24.8% | -2.9% | ||
| Q4 24 | — | -2.8% | ||
| Q3 24 | 11.4% | -13.1% | ||
| Q2 24 | -39.5% | -7.7% | ||
| Q1 24 | — | -11.5% |
净利率INDVSFIX
| Q4 25 | 28.9% | -1.9% | ||
| Q3 25 | 13.4% | -2.8% | ||
| Q2 25 | 6.0% | -2.3% | ||
| Q1 25 | 17.7% | -2.1% | ||
| Q4 24 | — | -2.0% | ||
| Q3 24 | 7.2% | -11.4% | ||
| Q2 24 | -32.4% | -6.6% | ||
| Q1 24 | — | -10.8% |
每股收益（稀释后）INDVSFIX
| Q4 25 | $0.79 | $-0.05 | ||
| Q3 25 | $0.33 | $-0.06 | ||
| Q2 25 | $0.14 | $-0.06 | ||
| Q1 25 | $0.38 | $-0.05 | ||
| Q4 24 | — | $-0.05 | ||
| Q3 24 | $0.16 | $-0.29 | ||
| Q2 24 | $-0.72 | $-0.18 | ||
| Q1 24 | — | $-0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.0M | $244.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-98.0M | $204.1M |
| 总资产 | $1.2B | $530.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INDVSFIX
| Q4 25 | $195.0M | $244.2M | ||
| Q3 25 | $445.0M | $234.9M | ||
| Q2 25 | $510.0M | $234.2M | ||
| Q1 25 | $373.0M | $219.1M | ||
| Q4 24 | — | $253.3M | ||
| Q3 24 | — | $247.0M | ||
| Q2 24 | — | $244.5M | ||
| Q1 24 | — | $229.8M |
股东权益INDVSFIX
| Q4 25 | $-98.0M | $204.1M | ||
| Q3 25 | $-207.0M | $203.0M | ||
| Q2 25 | $-257.0M | $200.4M | ||
| Q1 25 | $-285.0M | $197.8M | ||
| Q4 24 | — | $190.5M | ||
| Q3 24 | $-310.0M | $187.0M | ||
| Q2 24 | $-281.0M | $208.9M | ||
| Q1 24 | — | $213.3M |
总资产INDVSFIX
| Q4 25 | $1.2B | $530.7M | ||
| Q3 25 | $1.4B | $480.6M | ||
| Q2 25 | $1.5B | $484.7M | ||
| Q1 25 | $1.4B | $472.6M | ||
| Q4 24 | — | $507.1M | ||
| Q3 24 | — | $486.9M | ||
| Q2 24 | — | $537.0M | ||
| Q1 24 | — | $538.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-221.0M | $10.9M |
| 自由现金流经营现金流 - 资本支出 | $-245.0M | $5.6M |
| 自由现金流率自由现金流/营收 | -68.6% | 1.6% |
| 资本支出强度资本支出/营收 | 6.7% | 1.6% |
| 现金转化率经营现金流/净利润 | -2.15× | — |
| 过去12个月自由现金流最近4个季度 | $-93.0M | $4.9M |
8季度趋势，按日历期对齐
经营现金流INDVSFIX
| Q4 25 | $-221.0M | $10.9M | ||
| Q3 25 | $-39.0M | $7.0M | ||
| Q2 25 | $158.0M | $20.5M | ||
| Q1 25 | $75.0M | $-16.2M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $2.0M | $8.2M | ||
| Q2 24 | $88.0M | $21.7M | ||
| Q1 24 | — | $-22.3M |
自由现金流INDVSFIX
| Q4 25 | $-245.0M | $5.6M | ||
| Q3 25 | $-59.0M | $2.8M | ||
| Q2 25 | $141.0M | $16.0M | ||
| Q1 25 | $70.0M | $-19.4M | ||
| Q4 24 | — | $9.9M | ||
| Q3 24 | $-5.0M | $4.5M | ||
| Q2 24 | $84.0M | $18.9M | ||
| Q1 24 | — | $-26.1M |
自由现金流率INDVSFIX
| Q4 25 | -68.6% | 1.6% | ||
| Q3 25 | -18.8% | 0.9% | ||
| Q2 25 | 46.7% | 4.9% | ||
| Q1 25 | 26.3% | -6.2% | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | -1.6% | 1.4% | ||
| Q2 24 | 28.1% | 5.9% | ||
| Q1 24 | — | -7.9% |
资本支出强度INDVSFIX
| Q4 25 | 6.7% | 1.6% | ||
| Q3 25 | 6.4% | 1.4% | ||
| Q2 25 | 5.6% | 1.4% | ||
| Q1 25 | 1.9% | 1.0% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | 2.3% | 1.2% | ||
| Q2 24 | 1.3% | 0.9% | ||
| Q1 24 | — | 1.1% |
现金转化率INDVSFIX
| Q4 25 | -2.15× | — | ||
| Q3 25 | -0.93× | — | ||
| Q2 25 | 8.78× | — | ||
| Q1 25 | 1.60× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.09× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INDV
| Sublocade | $233.0M | 65% |
| Sublingual And Other | $69.0M | 19% |
| Other | $49.0M | 14% |
| Perseris | $6.0M | 2% |
SFIX
暂无分部数据
